Fig. 4From: Folic acid-targeted iron oxide nanoparticles as contrast agents for magnetic resonance imaging of human ovarian cancerMTT assay of Skov-3 cell viability after treatment with PBS (control) and the FA-targeted Fe3O4 NPs or non-targeted Fe3O4 NPs at the Fe concentration of 0.25–1.00 mM for 24 hBack to article page